Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllSEC EDGARECBWhite HouseFederal ReserveBank of EnglandDOJBank of Japan
TopicAllenforcementfilingsmonetarypolicy

2450 items from SEC EDGAR · filings · clear filters

  • SEC EDGARfilings
    8-K - TransDigm Group INC (0001260221) (Filer)

    TransDigm Group Inc. filed a Form 8-K with the SEC on July 13, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001260221-26-000044, 155 KB).

  • SEC EDGARfilings
    8-K - N-able, Inc. (0001834488) (Filer)

    N-able, Inc. filed a Form 8-K on July 13, 2026 reporting the departure of certain officers and directors, related compensatory arrangements, and other events.

  • SEC EDGARfilings
    8-K - Future Vision II Acquisition Corp. (0002010653) (Filer)

    Future Vision II Acquisition Corp. filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation, unregistered equity sales, other events, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Cue Biopharma, Inc. (0001645460) (Filer)

    Cue Biopharma, Inc. filed an 8-K reporting a material definitive agreement, unregistered sales of equity securities, changes to directors and officers with related compensation arrangements, other events, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Vivakor, Inc. (0001450704) (Filer)

    Vivakor, Inc. filed a Form 8-K reporting a material definitive agreement, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Aterian, Inc. (0001757715) (Filer)

    Aterian, Inc. filed a Form 8-K on July 10, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Burtech Acquisition Corp II (0002098707) (Filer)

    Burtech Acquisition Corp II filed a Form 8-K on July 10, 2026 (Accession No. 0001213900-26-077285), including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Tenon Medical, Inc. (0001560293) (Filer)

    Tenon Medical, Inc. filed a Form 8-K with the SEC on July 10, 2026, under Item 8.01 (Other Events), accession number 0001213900-26-077274, comprising 237 KB of information.

  • SEC EDGARfilings
    8-K - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Filer)

    Cognizant Technology Solutions Corp filed a Form 8-K on July 10, 2026, containing a Regulation FD disclosure and its financial statements and related exhibits, as documented in accession number 0001058290-26-000025.

  • SEC EDGARfilings
    8-K - Cellectar Biosciences, Inc. (0001279704) (Filer)

    Cellectar Biosciences filed a Form 8-K on July 10, 2026, reporting director and officer departures and appointments, related compensation arrangements, matters submitted for a shareholder vote, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - National Storage Affiliates Trust (0001618563) (Filer)

    National Storage Affiliates Trust filed a Form 8-K on July 10, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - BiomX Inc. (0001739174) (Filer)

    BiomX Inc. filed a Form 8-K on July 10, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - DarioHealth Corp. (0001533998) (Filer)

    DarioHealth Corp. filed a Form 8-K on July 10, 2026 disclosing the departure of directors or officers, the election and appointment of directors and officers, and related compensatory arrangements for certain officers.

  • SEC EDGARfilings
    8-K - Kinetic Seas Inc. (0001945619) (Filer)

    Kinetic Seas Inc. filed an 8-K on July 10, 2026 reporting departures, elections or appointments of directors and officers, associated compensatory arrangements, and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Plum Acquisition Corp, IV (0002030482) (Filer)

    Plum Acquisition Corp. IV filed a Form 8-K on July 10, 2026, reporting entry into a material definitive agreement and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - LANDS' END, INC. (0000799288) (Filer)

    Lands' End, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and disclosed compensatory arrangements for the appointed officers.

  • SEC EDGARfilings
    8-K - Columbus Circle Capital Corp III (0002123471) (Filer)

    Columbus Circle Capital Corp III filed a Form 8-K on July 10, 2026 reporting a material definitive agreement, unregistered sales of equity securities, changes to directors and officers, amendments to its articles and bylaws, other events, and accompanying financial statements.

  • SEC EDGARfilings
    8-K - AMASS BRANDS (0001851491) (Filer)

    Amass Brands filed an 8-K on July 10, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - HeartSciences Inc. (0001468492) (Filer)

    HeartSciences Inc. filed a Form 8-K reporting unregistered sales of equity securities, departures and appointments of directors and officers with associated compensatory arrangements, and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - SOLESENCE, INC. (0000883107) (Filer)

    Solesence, Inc. filed a Form 8-K on July 10, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - National Healthcare Properties, Inc. (0001561032) (Filer)

    National Healthcare Properties, Inc. filed an 8-K on July 10, 2026 reporting director and officer departures, elections, appointments, and related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGARfilings
    8-K - SKYX Platforms Corp. (0001598981) (Filer)

    SKYX Platforms Corp. filed a Form 8-K on July 10, 2026, indicating that it has submitted certain matters to its security holders for a vote, as required under Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - Via Transportation, Inc. (0001603015) (Filer)

    Via Transportation, Inc. filed a Form 8-K reporting the departure of certain officers, the election or appointment of directors and officers, and disclosed compensatory arrangements for those officers.

  • SEC EDGARfilings
    8-K - NXG NextGen Infrastructure Income Fund (0001506488) (Filer)

    NXG NextGen Infrastructure Income Fund filed a Form 8-K on July 10, 2026, reporting other events and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - LINCOLN EDUCATIONAL SERVICES CORP (0001286613) (Filer)

    Lincoln Educational Services Corp filed a Form 8-K reporting a material definitive agreement, completion of an acquisition or asset disposition, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - TRUSTCO BANK CORP N Y (0000357301) (Filer)

    Trustco Bank Corp filed a Form 8-K on July 10, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    Sunshine Biopharma filed a Form 8-K on July 10, 2026 reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    Concentra Group Holdings Parent, Inc. filed an 8-K on July 10, 2026 reporting director and officer departures, elections, appointments, related compensatory arrangements, and including financial statements and exhibits.

  • SEC EDGARfilings
    8-K - BIOFORCE NANOSCIENCES HOLDINGS, INC. (0001310488) (Filer)

    BiForce Nanosciences Holdings, Inc. filed a Form 8-K on July 7 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - AZZ INC (0000008947) (Filer)

    AZZ Inc. filed a Form 8-K on July 7, 2026, including Item 5.07 concerning matters submitted for a security-holder vote and Item 9.01 providing financial statements and related exhibits.